Action of treosulfan in myelin-oligodendrocyte-glycoprotein-induced experimental autoimmune encephalomyelitis and human lymphocytes
- 1 November 2003
- journal article
- Published by Elsevier in Journal of Neuroimmunology
- Vol. 144 (1-2) , 28-37
- https://doi.org/10.1016/j.jneuroim.2003.08.028
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Mitoxantrone in progressive multiple sclerosis: a placebo-controlled, double-blind, randomised, multicentre trialThe Lancet, 2002
- Therapy-related acute myeloblastic leukemia after mitoxantrone treatment in a patient with MSNeurology, 2002
- Multiple sclerosisThe Lancet, 2002
- A Longitudinal Study of Abnormalities on MRI and Disability from Multiple SclerosisNew England Journal of Medicine, 2002
- High-dose chemotherapy with peripheral blood stem cell transplantation for patients with advanced ovarian cancerZeitschrift für Krebsforschung und Klinische Onkologie, 2001
- Monoclonal antibody treatment exposes three mechanisms underlying the clinical course of multiple sclerosisAnnals of Neurology, 1999
- Identification of autoantibodies associated with myelin damage in multiple sclerosisNature Medicine, 1999
- DNA alkylation and interstrand cross-linking by treosulfanBritish Journal of Cancer, 1998
- Treosulfan as an Effective Second-Line Therapy in Ovarian CancerGynecologic Oncology, 1998
- Therapeutic effect of mitoxantrone combined with methylprednisolone in multiple sclerosis: a randomised multicentre study of active disease using MRI and clinical criteria.Journal of Neurology, Neurosurgery & Psychiatry, 1997